Overexpression of SSR2 promotes proliferation of liver cancer cells and predicts prognosis of patients with hepatocellular carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Overexpression of SSR2 promotes proliferation of liver cancer cells and predicts prognosis of patients with hepatocellular carcinoma

Published:2022-04-28 Issue:11 Volume:26 Page:3169-3182
ISSN:1582-1838
Container-title:Journal of Cellular and Molecular Medicine
language:en
Short-container-title:J Cellular Molecular Medi

Author:

Chen Fengsui¹²^ORCID,Chen Xingchi²,Wang Jielong²,Zhang Shi‘an¹,Chen Mengxue³,Zhang Xia¹²,Wu Zhixian¹²

Affiliation:

1. Department of Hepatobiliary Disease 900 Hospital of the Joint Logistics Support Force Fujian Medical University Fuzhou Fujian P.R. China

2. Department of Hepatobiliary Disease 900 Hospital of the Joint Logistics Support Force (Dongfang Hospital) Xiamen University Fuzhou Fujian P.R. China

3. Fuzhou Hospital of Traditional Chinese Medicine Fuzhou Fujian P.R. China

Funder

Fujian Provincial Department of Science and Technology

Natural Science Foundation of Fujian Province

Fujian Provincial Department of Education

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcmm.17314

Reference16 articles.

1. Update in global trends and aetiology of hepatocellular carcinoma

2. A Novel Five-Gene Signature for Prognosis Prediction in Hepatocellular Carcinoma

3. Transplantation versus liver resection in patients with hepatocellular carcinoma

4. Comparison of Prognostic Scores in Patients With Hepatocellular Carcinoma Treated With Sorafenib

5. SSR alpha and associated calnexin are major calcium binding proteins of the endoplasmic reticulum membrane.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP